115 related articles for article (PubMed ID: 15640959)
1. Early nuclear alterations and immunohistochemical expression of Ki-67, Erb-B2, vascular endothelial growth factor (VEGF), transforming growth factor (TGF-beta1) and integrine-linked kinase (ILK) two days after tamoxifen in breast carcinoma.
Morena AM; Oshima CT; Gebrim LH; Egami MI; Silva MR; Segreto RA; Giannotti Filho O; Teixeira VP; Segreto HR
Neoplasma; 2004; 51(6):481-6. PubMed ID: 15640959
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
[TBL] [Abstract][Full Text] [Related]
3. Can transforming growth factor-beta1 and retinoids modify the activity of estradiol and antiestrogens in MCF-7 breast cancer cells?
Czeczuga-Semeniuk E; Anchim T; Dziecioł J; Dabrowska M; Wołczyński S
Acta Biochim Pol; 2004; 51(3):733-45. PubMed ID: 15448735
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of TGF-alpha, TGF-beta1, EGFR, and IGF-1 expression in human breast carcinoma.
Pilichowska M; Kimura N; Fujiwara H; Nagura H
Mod Pathol; 1997 Oct; 10(10):969-75. PubMed ID: 9346175
[TBL] [Abstract][Full Text] [Related]
5. Expression of transforming growth factor-beta1 and hypoxia-inducible factor-1alpha in an experimental model of kidney transplantation.
Lario S; Mendes D; Bescós M; Iñigo P; Campos B; Alvarez R; Alcaraz A; Rivera-Fillat F; Campistol JM
Transplantation; 2003 May; 75(10):1647-54. PubMed ID: 12777850
[TBL] [Abstract][Full Text] [Related]
6. Role of integrin-linked kinase in epithelial-mesenchymal transition in crescent formation of experimental glomerulonephritis.
Shimizu M; Kondo S; Urushihara M; Takamatsu M; Kanemoto K; Nagata M; Kagami S
Nephrol Dial Transplant; 2006 Sep; 21(9):2380-90. PubMed ID: 16728424
[TBL] [Abstract][Full Text] [Related]
7. HER-2/neu-Positive breast carcinoma: molecular concomitants by proteomic analysis and their therapeutic implications.
Brown RE
Ann Clin Lab Sci; 2002; 32(1):12-21. PubMed ID: 11848612
[TBL] [Abstract][Full Text] [Related]
8. Short-term biologic response to withdrawal of hormone replacement therapy in patients with invasive breast carcinoma.
Prasad R; Boland GP; Cramer A; Anderson E; Knox WF; Bundred NJ
Cancer; 2003 Dec; 98(12):2539-46. PubMed ID: 14669271
[TBL] [Abstract][Full Text] [Related]
9. Effects of tamoxifen on transcriptional level of transforming growth factor beta (TGF-beta) isoforms 1 and 2 in tumor tissue during primary treatment of patients with breast cancer.
Brandt S; Kopp A; Grage B; Knabbe C
Anticancer Res; 2003; 23(1A):223-9. PubMed ID: 12680217
[TBL] [Abstract][Full Text] [Related]
10. Expression of c-erbB-2 oncogene protein, epidermal growth factor receptor, and TGF-beta1 in human pancreatic ductal adenocarcinoma.
Zhang L; Yuan SZ
Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):620-3. PubMed ID: 14607699
[TBL] [Abstract][Full Text] [Related]
11. Expression of cyclo-oxygenase 1 and 2, prostaglandin E synthase and transforming growth factor beta1, and their relationship with vascular endothelial growth factors A and C, in primary adenocarcinoma of the small intestine.
von Rahden BH; Brücher BL; Langner C; Siewert JR; Stein HJ; Sarbia M
Br J Surg; 2006 Nov; 93(11):1424-32. PubMed ID: 17022010
[TBL] [Abstract][Full Text] [Related]
12. Expression of transforming growth factor-beta1 and transforming growth factor-beta receptors in hepatocellular carcinoma and dysplastic nodules.
Paik SY; Park YN; Kim H; Park C
Mod Pathol; 2003 Jan; 16(1):86-96. PubMed ID: 12527718
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
Rydén L; Jirström K; Bendahl PO; Fernö M; Nordenskjöld B; Stål O; Thorstenson S; Jönsson PE; Landberg G
J Clin Oncol; 2005 Jul; 23(21):4695-704. PubMed ID: 16034044
[TBL] [Abstract][Full Text] [Related]
14. Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment.
Butta A; MacLennan K; Flanders KC; Sacks NP; Smith I; McKinna A; Dowsett M; Wakefield LM; Sporn MB; Baum M
Cancer Res; 1992 Aug; 52(15):4261-4. PubMed ID: 1322240
[TBL] [Abstract][Full Text] [Related]
15. [The effects of tamoxifen on human hepatocellular carcinoma cell proliferation and transforming growth factor-beta1 expression].
Shin JW; Chung YH; Park MI; Kim JA; Choi MH; Lee YJ; Ryu SH; Park NH; Lee HC; Lee YS; Suh DJ; Yu ES
Taehan Kan Hakhoe Chi; 2003 Mar; 9(1):10-6. PubMed ID: 12657824
[TBL] [Abstract][Full Text] [Related]
16. Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression.
Sadick H; Riedel F; Naim R; Goessler U; Hörmann K; Hafner M; Lux A
Haematologica; 2005 Jun; 90(6):818-28. PubMed ID: 15951295
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta1 upregulates myostatin expression in mouse C2C12 myoblasts.
Budasz-Rwiderska M; Jank M; Motyl T
J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():195-214. PubMed ID: 16077203
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of receptor-tyrosine kinase c-kit protein and TGF-beta1 in invasive ductal carcinoma of the pancreas.
Nio Y; Omori H; Hashimoto K; Itakura M; Koike M; Yano S; Toga T; Higami T; Maruyama R
Anticancer Res; 2005; 25(5):3523-9. PubMed ID: 16101174
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D-1, interleukin-6, HER-2/neu, transforming growth factor receptor-II and prediction of relapse in women with early stage, hormone receptor-positive breast cancer treated with tamoxifen.
Muss HB; Bunn JY; Crocker A; Plaut K; Koh J; Heintz N; Rincon M; Weaver DL; Tam D; Beatty B; Kaufman P; Donovan M; Verbel D; Weiss L
Breast J; 2007; 13(4):337-45. PubMed ID: 17593037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]